“…However, despite these challenges, GC still form during chronic infection (Barnett et al, 2016;Daugan et al, 2016) and antibodies have been shown to diversify over time during chronic HIV and HCV infections (Doria-Rose et al, 2014;Kinchen et al, 2018;Wu et al, 2015), suggesting ongoing GC activity. Moreover, despite generally smaller GCs during chronic infection, affinity-matured antibodies produced as a result of the GC response exert partial but critical control of viral replication and, in some cases, lead to viral control (Chen et al, 2018;Chou et al, 2016;Doria-Rose et al, 2014;Kinchen et al, 2018). Additionally, non-neutralizing antibodies are required to partially contain infection in many cases (Barnett et al, 2016;Hangartner et al, 2006;Horwitz et al, 2017;Richter and Oxenius, 2013;Straub et al, 2013) and can apply selective pressure for viral escape and evolution in some settings (Doria-Rose et al, 2014;Kinchen et al, 2018;Wu et al, 2015).…”